120 related articles for article (PubMed ID: 30483798)
21. Differential impact of p16 inactivation by promoter methylation in non-small cell lung and colorectal cancer: clinical implications.
González-Quevedo R; García-Aranda C; Morán A; De Juan C; Sánchez-Pernaute A; Torres A; Díaz-Rubio E; Balibrea JL; Benito M; Iniesta P
Int J Oncol; 2004 Feb; 24(2):349-55. PubMed ID: 14719111
[TBL] [Abstract][Full Text] [Related]
22. Clinical and prognosis value of the CIMP status combined with MLH1 or p16
Saadallah-Kallel A; Abdelmaksoud-Dammak R; Triki M; Charfi S; Khabir A; Sallemi-Boudawara T; Mokdad-Gargouri R
Med Oncol; 2017 Aug; 34(8):147. PubMed ID: 28730335
[TBL] [Abstract][Full Text] [Related]
23. [The study of 5-Aza-2'-deoxycytidine on transcription regulation of p16/CDKN2 gene demethylation in RKO human colorectal cell line].
Fang XM; Sun LF; Peng JP; Dong Q; Zheng S
Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(23):2077-82. PubMed ID: 14703421
[TBL] [Abstract][Full Text] [Related]
24. Detection of aberrant p16 methylation in the serum of colorectal cancer patients.
Zou H; Yu B; Zhao R; Wang Z; Cang H; Li D; Feng G; Yi J
Zhonghua Yu Fang Yi Xue Za Zhi; 2002 Dec; 36(7):499-501. PubMed ID: 12411153
[TBL] [Abstract][Full Text] [Related]
25. Expression of the hMLH1 gene is a possible predictor for the clinical response to 5-fluorouracil after a surgical resection in colorectal cancer.
Ide T; Kitajima Y; Ohtaka K; Mitsuno M; Nakafusa Y; Miyazaki K
Oncol Rep; 2008 Jun; 19(6):1571-6. PubMed ID: 18497967
[TBL] [Abstract][Full Text] [Related]
26. Hypermethylation of the CDKN2A gene in colorectal cancer is associated with shorter survival.
Maeda K; Kawakami K; Ishida Y; Ishiguro K; Omura K; Watanabe G
Oncol Rep; 2003; 10(4):935-8. PubMed ID: 12792748
[TBL] [Abstract][Full Text] [Related]
27. Hypermethylation of the p16 gene in sporadic T3N0M0 stage colorectal cancers: association with DNA replication error and shorter survival.
Liang JT; Chang KJ; Chen JC; Lee CC; Cheng YM; Hsu HC; Wu MS; Wang SM; Lin JT; Cheng AL
Oncology; 1999; 57(2):149-56. PubMed ID: 10461063
[TBL] [Abstract][Full Text] [Related]
28. P16 methylation in serum as a potential marker for the malignancy of colorectal carcinoma.
Nakayama G; Hibi K; Kodera Y; Koike M; Fujiwara M; Nakao A
Anticancer Res; 2007; 27(5A):3367-70. PubMed ID: 17970082
[TBL] [Abstract][Full Text] [Related]
29. Relationships between p16 gene promoter methylation and clinicopathologic features of colorectal cancer: a meta-analysis of 27 cohort studies.
Chen YZ; Liu D; Zhao YX; Wang HT; Gao Y; Chen Y
DNA Cell Biol; 2014 Oct; 33(10):729-38. PubMed ID: 24979649
[TBL] [Abstract][Full Text] [Related]
30. Detection of aberrant p16 methylation in the serum of colorectal cancer patients.
Zou HZ; Yu BM; Wang ZW; Sun JY; Cang H; Gao F; Li DH; Zhao R; Feng GG; Yi J
Clin Cancer Res; 2002 Jan; 8(1):188-91. PubMed ID: 11801557
[TBL] [Abstract][Full Text] [Related]
31. Differences in loss of p16INK4 protein expression by promoter methylation between left- and right-sided primary colorectal carcinomas.
Schneider-Stock R; Boltze C; Peters B; Höpfner T; Meyer F; Lippert H; Roessner A
Int J Oncol; 2003 Oct; 23(4):1009-13. PubMed ID: 12963980
[TBL] [Abstract][Full Text] [Related]
32. p16 gene methylation in colorectal cancer patients with long-term follow-up.
Veganzones-de-Castro S; Rafael-Fernández S; Vidaurreta-Lázaro M; de-la-Orden V; Mediero-Valeros B; Fernández C; Maestro-de las Casas ML
Rev Esp Enferm Dig; 2012 Mar; 104(3):111-7. PubMed ID: 22449151
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms of inactivation of the p16INK4a gene in leiomyosarcoma of soft tissue: decreased p16 expression correlates with promoter methylation and poor prognosis.
Kawaguchi K; Oda Y; Saito T; Yamamoto H; Tamiya S; Takahira T; Miyajima K; Iwamoto Y; Tsuneyoshi M
J Pathol; 2003 Nov; 201(3):487-95. PubMed ID: 14595762
[TBL] [Abstract][Full Text] [Related]
34. Promoter methylation and expression of SOCS-1 affect clinical outcome and epithelial-mesenchymal transition in colorectal cancer.
Kang XC; Chen ML; Yang F; Gao BQ; Yang QH; Zheng WW; Hao S
Biomed Pharmacother; 2016 May; 80():23-29. PubMed ID: 27133036
[TBL] [Abstract][Full Text] [Related]
35. Promoter methylation of p16, Runx3, DAPK and CHFR genes is frequent in gastric carcinoma.
Hu SL; Kong XY; Cheng ZD; Sun YB; Shen G; Xu WP; Wu L; Xu XC; Jiang XD; Huang DB
Tumori; 2010; 96(5):726-33. PubMed ID: 21302620
[TBL] [Abstract][Full Text] [Related]
36. Hypermethylation of p16 gene promoter correlates with loss of p16 expression that results in poorer prognosis in esophageal squamous cell carcinomas.
Fujiwara S; Noguchi T; Takeno S; Kimura Y; Fumoto S; Kawahara K
Dis Esophagus; 2008; 21(2):125-31. PubMed ID: 18269647
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of the expression levels of the p16, p15, and p14 genes in dogs with high-grade lymphoma.
Fujiwara-Igarashi A; Goto-Koshino Y; Sato M; Maeda S; Igarashi H; Takahashi M; Fujino Y; Ohno K; Tsujimoto H
Vet J; 2014 Feb; 199(2):236-44. PubMed ID: 24365070
[TBL] [Abstract][Full Text] [Related]
38. Aberrant expression of pRb and p16(INK4), alone or in combination, indicates poor outcome after resection in patients with colorectal carcinoma.
Cui X; Shirai Y; Wakai T; Yokoyama N; Hirano S; Hatakeyama K
Hum Pathol; 2004 Oct; 35(10):1189-95. PubMed ID: 15492985
[TBL] [Abstract][Full Text] [Related]
39. A cancer-prone case with a background of methylation of p16 tumor suppressor gene.
Hibi K; Koike M; Nakayama H; Fujitake S; Kasai Y; Ito K; Akiyama S; Nakao A
Clin Cancer Res; 2003 Mar; 9(3):1053-6. PubMed ID: 12631606
[TBL] [Abstract][Full Text] [Related]
40. Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis.
Xu XL; Yu J; Zhang HY; Sun MH; Gu J; Du X; Shi DR; Wang P; Yang ZH; Zhu JD
World J Gastroenterol; 2004 Dec; 10(23):3441-54. PubMed ID: 15526363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
